Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Fibromatosis, Aggressive
- Cryoablation Versus Medical Therapy in Desmoid Tumors Progressing After Watchful Waiting
- Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study
- A Randomized, Double-blind,Phase Ⅲ Study of Liposome Doxorubicin in Desmoid Tumor
- Clinical Study of Anlotinib Combined With Chemotherapy in the Treatment of Unresectable Advanced Desmoid Tumor
- A Study of AL102 in Patients With Progressing Desmoid Tumors
- Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery
- A Study to Evaluate the Safety and Efficacy of Vactosertib and Imatinib in Patients With Advanced Desmoid Tumor
- Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)
- A Pilot Study of Intralesional Injection of Triamcinolone Acetonide for Desmoid Tumors
- Phase I, Open-label, Non-randomized Study to Evaluate Safety of BC2059
- Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies
- Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Round Cell Tumors and Ewing Sarcoma
- Compassionate Use Protocol for PF-03084014 in Patients With Advanced Solid Tumor Malignancies
- A Trial of Imatinib for Patients With Aggressive Desmoid Tumor (Aggressive Fibromatosis)
- 18F-FES PET/CT in Imaging Patients With Desmoid Tumors
- Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets
- Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis
- Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis
- Safety and Efficacy Study Using 5-ALA Oral Administration as an Adjuvant Therapy on the Rate of Local Tumor Recurrence in Patients Who Have Desmoids Tumors
- PAZOPANIB Efficacy and Tolerance in Desmoids Tumors
- Endoxifen in Adults With Hormone Receptor Positive Solid Tumors
- A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis
- Study to Evaluate Imatinib in Desmoid Tumors
- Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors
- Imatinib in Patients With Desmoid Tumor and Chondrosarcoma
- Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas
- Imatinib Mesylate in Treating Patients With Recurrent or Refractory Fibromatosis
- Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor
- Vinblastine and Methotrexate in Treating Children With Desmoid Tumors
- Toremifene in Treating Patients With Desmoid Tumors